Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received November 20, 2014
- Accepted January 2, 2015
- Published online March 18, 2015.
Article Versions
- You are currently viewing a previous version of this article (March 18, 2015 - 23:37).
- View the most recent version of this article
Copyright & Usage
The content of this work is ©the authors or their employers. Design and branding are ©ERS 2015. ERJ Open articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. This article is one of a small annual allocation selected for open access publication at the discretion of the editor.
Author Information
- Knut Lönnroth1,60,
- Giovanni Battista Migliori2,60,
- Ibrahim Abubakar3,
- Lia D'Ambrosio2,
- Gerard de Vries4,
- Roland Diel5,
- Paul Douglas6,
- Dennis Falzon1,
- Marc-Andre Gaudreau7,
- Delia Goletti8,
- Edilberto R. González Ochoa9,
- Philip LoBue10,
- Alberto Matteelli1,
- Howard Njoo7,
- Ivan Solovic11,
- Alistair Story12,
- Tamara Tayeb13,
- Marieke J. van der Werf14,
- Diana Weil1,
- Jean-Pierre Zellweger15,
- Mohamed Abdel Aziz16,
- Mohamed R.M. Al Lawati17,
- Stefano Aliberti18,
- Wouter Arrazola de Oñate19,
- Draurio Barreira20,
- Vineet Bhatia1,
- Francesco Blasi21,
- Amy Bloom22,
- Judith Bruchfeld23,
- Francesco Castelli24,
- Rosella Centis2,
- Daniel Chemtob25,
- Daniela M. Cirillo26,
- Alberto Colorado27,
- Andrei Dadu28,
- Ulf R. Dahle29,
- Laura De Paoli30,
- Hannah M. Dias1,
- Raquel Duarte31,
- Lanfranco Fattorini32,
- Mina Gaga33,
- Haileyesus Getahun1,
- Philippe Glaziou1,
- Lasha Goguadze34,
- Mirtha del Granado35,
- Walter Haas36,
- Asko Järvinen37,38,
- Geun-Yong Kwon39,
- Davide Mosca40,
- Payam Nahid41,42,
- Nobuyuki Nishikiori43,
- Isabel Noguer44,
- Joan O'Donnell45,
- Analita Pace-Asciak46,
- Maria G. Pompa47,
- Gilda G. Popescu48,
- Carlos Robalo Cordeiro49,
- Karin Rønning29,
- Morten Ruhwald50,
- Jean-Paul Sculier51,
- Aleksandar Simunović52,
- Alison Smith-Palmer53,
- Giovanni Sotgiu54,
- Giorgia Sulis1,
- Carlos A. Torres-Duque55,
- Kazunori Umeki56,
- Mukund Uplekar1,
- Catharina van Weezenbeek4,
- Tuula Vasankari37,
- Robert J. Vitillo57,
- Constantia Voniatis58,
- Maryse Wanlin59 and
- Mario C. Raviglione1
- 1Global TB Programme, World Health Organization, Geneva, Switzerland
- 2WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, IRCCS, Tradate, Italy
- 3TB Section, University College London and Public Health England, London, UK
- 4KNCV Tuberculosis Foundation, The Hague, The Netherlands
- 5University Hospital Schleswig Holstein, Institute for Epidemiology, Kiel, Germany
- 6Global Health Borders Refugee and Onshore Services, Dept of Immigration and Border Protection, Sydney, Australia
- 7Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Montreal, QC, Canada
- 8National Institute for Infectious Diseases, Rome, Italy
- 9Research and Surveillance Group on TB, Leprosy and ARI, Epidemiology Board, Institute of Tropical Medicine “Pedro Kourí”, Havana, Cuba
- 10Division of TB Elimination, Centers for Disease Control and Prevention, Atlanta, GA, USA
- 11TB Dept, National Institute for TB, Respiratory Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ružomberok, Slovakia
- 12Find and Treat, London, UK
- 13National TB Control Programme, Ministry of Health, Riyadh, Saudi Arabia
- 14European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- 15Swiss Lung Association, Bern, Switzerland
- 16WHO Regional Office for the Eastern Mediterranean, Cairo, Egypt
- 17Ministry of Health, Muscat, Oman
- 18Università degli Studi di Milano – Bicocca, UO Clinica Pneumologica, AO San Gerardo, Monza, Italy
- 19Belgian Lung and Tuberculosis Association, Brussels, Belgium
- 20Ministry of Health, Brasilia, Brazil
- 21Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, Italy
- 22US Agency for International Development, Washington, DC, USA
- 23Unit of Infectious Diseases, Institution of Medicine, Karolinska Institute Solna and Karolinska University Hospital, Stockholm, Sweden
- 24University of Brescia, Brescia, Italy
- 25Ministry of Health, Jerusalem, Israel
- 26IRCCS San Raffaele Scientific Institute, Milan, Italy
- 27Advocates for Health International, San Diego, CA, USA
- 28TB and M/XDR-TB Control Programme, WHO Regional Office for Europe, Copenhagen, Denmark
- 29Norwegian Institute of Public Health, Oslo, Norway
- 30Médecins sans Frontières, Rome, Italy
- 31General Directorate of Health, Lisbon, Portugal
- 32Istituto Superiore di Sanita, Rome, Italy
- 33National Referral Centre for Mycobacteria, Athens Chest Hospital, Ministry of Health, Athens, Greece
- 34International Federation of Red Cross and Red Crescent Societies, Geneva, Switzerland
- 35WHO Regional Office for the Americas, Washington, DC, USA
- 36Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
- 37Finnish Lung Health Association, Helsinki, Finland
- 38Helsinki University Central Hospital, Division of Infectious Diseases, Helsinki, Finland
- 39Korea Centers for Disease Control and Prevention (KCDC), Ministry of Health and Welfare, Seoul, Republic of Korea
- 40International Organization for Migration, Geneva, Switzerland
- 41University of California, San Francisco, CA, USA
- 42American Thoracic Society (ATS), New York, NY, USA
- 43Stop TB and Leprosy Elimination, WHO Regional Office for the Western Pacific, Manila, Philippines
- 44Instituto de Salud Carlos III, Madrid, Spain
- 45HSE Health Protection Surveillance Centre, Dublin, Ireland
- 46Ministry for Health, Valletta, Malta
- 47Ministry of Health, Rome, Italy
- 48Pneumology Institute Marius Nasta, Bucharest, Romania
- 49Coimbra University Hospital, Coimbra, Portugal
- 50Statens Serum Institut (SSI), Copenhagen, Denmark
- 51Institut Jules Bordet (ULB), Brussels, Belgium
- 52Croatian National Institute of Public Health, Zagreb, Croatia
- 53Health Protection Scotland, Glasgow, UK
- 54Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy
- 55Asociacion Latinoamericana de Torax (ALAT) - Fundacion Neumologica Colombiana, Bogota, Colombia
- 56Ministry of Health, Labour and Welfare, Tokyo, Japan
- 57Caritas Internationalis, Geneva, Switzerland
- 58Ministry of Health, Nicosia, Cyprus
- 59Fonds des Affections Respiratoires (FARES), Brussels, Belgium
- 60Both authors contributed equally
- Mario C. Raviglione, Global TB Programme, World Health Organization, 20 avenue Appia, CH-1211, Geneva 27, Switzerland. E-mail: raviglionem{at}who.int
Funding
European Respiratory Society
core funding